High Cytoplasmic CXCR4 Expression Predicts Prolonged Survival in Triple-Negative Breast Cancer Patients Treated with Adjuvant Chemotherapy

• Egile Nagusiak: Bobae Shim (Egilea), Min-Sun Jin (Egilea), Ji Hye Moon (Egilea), In Ae Park (Egilea), Han Suk Ryu (Egilea)
• Formatua: Liburua
• Argitaratua: Korean Society of Pathologists & the Korean Society for Cytopathology, 2018-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background Chemokine receptor CXC chemokine receptor type 4 (CXCR4) and its ligand CXC motif chemokine 12 (CXCL12; stromal cell-derived factor-1) are implicated in tumor growth, metastasis, and tumor cell-microenvironment interaction. A number of studies have reported that increased CXCR4 expression...